mobilemenuClose menu
Highlighting the view of the respiratory health community to the EU
Highlighting the view of the respiratory health community to the EU

Highlighting the view of the respiratory health community to the EU

12-11-2021

The EU has initiated a public consultation

@eu-ipff is working with its partners of the European Lung Health Group Breathe Vision to highlight the view of the respiratory health community to the EU on its Revision of the EU general pharmaceuticals legislation.

The Breathe Vision is a collective initiative driven by European level patient groups and respiratory societies collaborating for better respiratory health care and protection of our lungs.

The public consultation aims to collect views of stakeholders and the general public in order to support the evaluation of the existing general pharmaceutical legislation on medicines for human use, and the impact assessment of its revision to ensure a future-proof and crisis-resistant medicines regulatory system.

It builds further on the public consultation conducted for the preparation of the Pharmaceutical Strategy for Europe of November 2020. The general pharmaceutical legislation sets the main definitions, regulatory incentives and authorisation procedures, as well as the manufacturing, authorisation and post-authorisation requirements for medicines.

Stakeholders and members of the general public, including patients, pharmacists and doctors are invited to contribute to this consultation. Organisations representing patients and civil society active in public health, healthcare professionals and providers, academia, researchers and the pharmaceutical industry may also express their view

The public consultation ends on 21.12.21 & we (EU-IPFF) urge patients to have their say at Revision of the EU general pharmaceuticals legislation (europa.eu). We will be sharing our submission prior to the deadline.

You can contribute to this consultation by filling in an online questionnaire, which you will find through the above link. If you are unable to use the online questionnaire, please respond via this e-mail address EU-PHARMACEUTICAL-STRATEGY@EC.EUROPA.EU.

The questionnaires are available in some or all official EU languages. You can submit your responses in any official EU language.

For reasons of transparency, organisations and businesses taking part in public consultations are asked to register in the EU’s Transparency Register.

EU IPFF

Search